Author: Customer Service

SUZHOU, China, April 29, 2026 (GLOBE NEWSWIRE) — YXT.com Group Holding Limited (NASDAQ: YXT) (“YXT.com” or the “Company”), a provider of AI-enabled enterprise productivity solutions, today announced that it has filed its annual report on Form 20-F for the fiscal year ended December 31, 2025 with the Securities and Exchange Commission on April 29, 2026 Eastern Time. The annual report can be accessed on the Company’s investor relations website at https://ir.yxt.com. About YXT.com YXT.com (NASDAQ: YXT) is a technology company focusing on enterprise productivity solutions. With a mission to “Empower people and organization development through technology,” the Company strives to become the supreme provider in building and boosting enterprise productivity by combining over a decade of experience in tech-enabled talent learning...

SYDNEY, April 29, 2026 (GLOBE NEWSWIRE) — Omni Bridgeway Limited (ASX: OBL), a leading global alternative asset manager specialising in legal assets, has released its Investment Portfolio Report as at 31 March 2026, highlighting a notably increased investment pipeline, continued positive completion metrics, and ongoing strength, scale and diversification of its global legal assets portfolio. Key HighlightsExceptionally Strong Investment Pipeline: Omni Bridgeway contracted 27 new investments FYTD, representing A$391.8 million in new commitments. This is supported by a pipeline of agreed exclusive term sheets representing over A$600 million in further commitments, if contracted — more than 2x the average quarterly pipeline value. This reflects favourable market and competitive dynamics, and an expanding opportunity set into 4Q26...

BOSTON, April 29, 2026 (GLOBE NEWSWIRE) — Avalyn Pharma Inc. (Nasdaq: AVLN) (“Avalyn”), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory diseases, today announced the pricing of its upsized initial public offering of 16,666,667 shares of its common stock at a price to the public of $18.00 per share. The gross proceeds to Avalyn from the offering, before deducting the underwriting discounts and commissions and offering expenses, are expected to be $300 million. All of the shares are being offered by Avalyn. In addition, Avalyn has granted the underwriters a 30-day option to buy an additional 2,500,000 shares of its common stock at the initial public offering price, less underwriting discounts and commissions. The shares are expected to begin trading...

ROCHESTER, N.Y., April 29, 2026 (GLOBE NEWSWIRE) — Vaccinex, Inc. (OTCMKTS:VCNX), a clinical-stage biotechnology company pioneering novel investigational antibody therapies in Alzheimer’s, Huntington’s disease, and cancer today released financial results for the year ended December 31, 2025. The financial statements have been posted on the company website. About Vaccinex, Inc. Vaccinex, Inc. is a clinical-stage immunotherapy company engaged in the discovery and development of targeted biotherapeutics to treat serious diseases and conditions with unmet medical needs, including neurodegenerative diseases, cancer, and autoimmune disorders, and is currently initiating a new Phase 2b study in Alzheimer’s disease. Vaccinex is based in Rochester, New York. Investor ContactElizabeth Evans, PhDChief Operating Officer, Vaccinex, Inc.(585)...

CALGARY, Alberta, April 29, 2026 (GLOBE NEWSWIRE) — Jura Energy Corporation (“Jura” or the “Company”) today announced the filing on SEDAR+ of its consolidated annual audited financial statements and management’s discussion and analysis for the years ended December 31, 2025 and 2024, as well as National Instrument 51-101 – Standards of Disclosure for Oil and Gas Activities, Form 51-101F1 Statement of Reserves Data and Other Oil and Gas Information as of December 31, 2025 (the “2025 Reserves Report”). As disclosed previously, Jura’s subsidiaries are involved in ongoing arbitrations (the “PEL Arbitrations”) with Petroleum Exploration (Private) Limited (“PEL”), the operator of the Badin IV North and Badin IV South blocks (together the “Badin Blocks”). Despite the arbitral award issued in favour of Jura’s...

Grand Cayman, Cayman Islands, April 29, 2026 (GLOBE NEWSWIRE) — Forefront Tech Holdings Acquisition Corp (the “Company”) announced today the pricing of its initial public offering of 10,000,000 units at $10.00 per unit. The units will be listed on The Nasdaq Global Market tier of The Nasdaq Stock Market LLC (“Nasdaq”) and begin trading on April 30, 2026, under the ticker symbol “FTHAU.” Each unit consists of one Class A ordinary share and one-half of one redeemable warrant, each whole warrant entitling the holder thereof to purchase one Class A ordinary share at a price of $11.50 per share, subject to certain adjustments. No fractional warrants will be issued upon separation of the units and only whole warrants will trade. Once the securities constituting the units begin separate trading, the Class A ordinary shares and warrants...